Your search for “Vita Capital II Ltd”

Secquaero Advisors AG has completed another value-in-force life insurance securitisation for Luxembourg domiciled life insurer Atlanticlux Lebensversicherung S.A, in a €70m SQ ReVita II IC Ltd. transaction featuring a closed-block of European life insurance.

Health insurance company Aetna has hailed the completion of its latest ILS transaction, Vitality Re VII Ltd. (Series 2016-1), which it says help it to “reduce its required capital” while gaining a $200m source of collateralized excess of loss reinsurance.

Health insurance firm Aetna’s $200m Vitality Re VII Ltd. (Series 2016-1) health insurance medical benefit ratio catastrophe bond deal has now been priced, with the coupon settling at the upper end of the initial guidance range.

Health insurance firm Aetna is returning to the capital markets in search of another $200 million or more of fully-collateralised reinsurance protection for losses under its health insurance medical benefit ratio, through a Vitality Re VII Ltd. (Series 2016-1) ILS issuance.

One of the world’s largest reinsurance companies Swiss Re is returning to the capital markets with its first excess mortality catastrophe bond transaction since 2012, seeking at least $100 million of retrocession through a Vita Capital VI Limited (Series 2015-1) issuance.

Fitch Ratings has affirmed two insurance-linked securities (ILS) transactions from Luxembourg-based life and annuity focused insurer ATLANTICLUX Lebensversicherung S.A., the SQ ReVita value-in-force (ViF) life securitisation and the Salam III Sukuk (Islamic bond).

Amlin, the London-headquartered non-life insurance and reinsurance business, appreciates the increased exposure to insurance-linked securities (ILS) that its larger stake in ILS investment manager Leadenhall Capital Partners LLP delivered, giving it a “foot in both camps.”

Health care insurance and benefits firm Aetna has hailed the improved “capital efficiency” and reduction in its “weighted average cost of capital” that it has achieved with the successful completion of its sixth medical benefit claims linked Vitality Re VI Ltd. (Series 2015-1) ILS.

Health insurer Aetna’s Vitality Re VI Ltd. (Series 2015-1) ILS has achieved the target size of $200m of protection for the sponsor, while the notes have been priced with one tranche near the lowest end of guidance and the other below it.

In a repeat of 2014, health insurer Aetna is the first sponsor to launch a new insurance-linked securities deal in 2015, with Vitality Re VI Ltd. (Series 2015-1) seeking at least $200m of protection linked to the insurers medical benefit claims ratio.